These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7505496)

  • 1. Thiacetazone--avoid like poison or use with care?
    Nunn P; Porter J; Winstanley P
    Trans R Soc Trop Med Hyg; 1993; 87(5):578-82. PubMed ID: 7505496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse cutaneous reactions to thiacetazone for tuberculosis treatment in Tanzania.
    Ipuge YA; Rieder HL; Enarson DA
    Lancet; 1995 Sep; 346(8976):657-60. PubMed ID: 7544858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness and total costs of three alternative strategies for the prevention and management of severe skin reactions attributable to thiacetazone in the treatment of Human Immunodeficiency Virus positive patients with tuberculosis in Kenya.
    van Gorkom J; Kibuga DK
    Tuber Lung Dis; 1996 Feb; 77(1):30-6. PubMed ID: 8733411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous hypersensitivity reactions due to thiacetazone in the treatment of tuberculosis in Zambian children infected with HIV-I.
    Chintu C; Luo C; Bhat G; Raviglione M; DuPont H; Zumla A
    Arch Dis Child; 1993 May; 68(5):665-8. PubMed ID: 7686737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous hypersensitivity reactions to thiacetazone, HIV infection and thiacetazone concentrations in plasma.
    Watkins WM; Mungai M; Muhia DK; Mberu EK; Gathua S; Winstanley PA; Gilks CF; Nunn P
    Br J Clin Pharmacol; 1996 Feb; 41(2):160-2. PubMed ID: 8838444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania.
    Dukes CS; Sugarman J; Cegielski JP; Lallinger GJ; Mwakyusa DH
    Trop Geogr Med; 1992 Oct; 44(4):308-11. PubMed ID: 1284179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life-threatening cutaneous reactions to thiacetazone-containing antituberculosis treatment in Kumasi, Ghana.
    Lawn SD; Frimpong EH; Acheampong JW
    West Afr J Med; 1999; 18(4):249-53. PubMed ID: 10734785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiacetazone toxicity in the treatment of tuberculosis patients in Nigeria.
    Pearson CA
    J Trop Med Hyg; 1978 Dec; 81(12):238-42. PubMed ID: 85717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous reactions to thiacetazone in Zambia--implications for tuberculosis treatment strategies.
    Kelly P; Buve A; Foster SD; McKenna M; Donnelly M; Sipatunyana G
    Trans R Soc Trop Med Hyg; 1994; 88(1):113-5. PubMed ID: 7512287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults.
    Okwera A; Johnson JL; Vjecha MJ; Wolski K; Whalen CC; Hom D; Huebner R; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):441-5. PubMed ID: 9441099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
    Kuaban C; Bercion R; Koulla-Shiro S
    East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic review: tuberculosis.
    Houston S; Pozniak A; Ray CS
    Cent Afr J Med; 1991 Aug; 37(8):250-9. PubMed ID: 1807799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-associated tuberculosis in developing countries: clinical features, diagnosis, and treatment.
    Raviglione MC; Narain JP; Kochi A
    Bull World Health Organ; 1992; 70(4):515-26. PubMed ID: 1394786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new tuberculosis.
    De Cock K
    Afr Health; 1994 Mar; 16(3):8-10. PubMed ID: 12318774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiacetazone skin reaction in Papua New Guinea.
    Naraqi S; Temu P
    Med J Aust; 1980 May; 1(10):480-1. PubMed ID: 6157976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
    Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn PP
    J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of thiacetazone blood levels and urinary excretion in man, using high performance liquid chromatography.
    Jenner PJ; Ellard GA; Swai OB
    Lepr Rev; 1984 Jun; 55(2):121-8. PubMed ID: 6205236
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cutaneous reactions to thiacetazone (TB1) (author's transl)].
    Strobel M; Ndiaye B; Marchand JP; Jovet JC
    Rev Fr Mal Respir; 1979; 7(5):467-70. PubMed ID: 95055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia.
    Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn P
    Trans R Soc Trop Med Hyg; 1995; 89(1):78-82. PubMed ID: 7747316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tropical respiratory medicine. 2. Impact of human immunodeficiency virus on tuberculosis in developing countries.
    Nunn PP; Elliott AM; McAdam KP
    Thorax; 1994 May; 49(5):511-8. PubMed ID: 8016777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.